Since its passage, the Bayh-Dole Act has bolstered U.S. economic output by $1.3 trillion, supported 4.2 million jobs, and helped lead to more than 11,000 start-up companies.

What is the Bayh-Dole Act?

Empowers universities, small businesses and non-profit institutions to take ownership of inventions made during federally-funded research, so they can license these basic inventions for further applied research and development and broader public use.

Encourages private-sector investment needed to turn basic government-funded research into tested and approved products, requires these products to be manufactured domestically and ensures royalties for universities to further advance basic research and education.

Allows the government to require additional licensing of inventions arising from its research if the invention is not being made available for public use or during public health or other national emergencies.

Enacted by Congress with strong bipartisan support to ensure basic innovations discovered through federal research are developed into real-life products, including approved therapies that reduce suffering, treat the sick and improve the lives of patients.

Innovation’s Golden Goose

Possibly the most inspired piece of legislation to be enacted in America over the past half-century was the Bayh-Dole Act of 1980… More than anything, this single policy measure helped to reverse America’s precipitous slide into industrial irrelevance.

– The Economist
Explore Bayh-Dole

Learn More about the 40 Years of Bayh-Dole

Read up on how the Bayh-Dole Act continues to make news in American and worldwide politics today.

Which industries benefit form the Bayh-Dole Act? What has changed in the 40 years since its passage? Find answers to these and more in our library of infographics.

The Bayh-Dole Act benefits the U.S. economy, taxpayers, consumers and patients, and we support the continuation of this vital piece of legislation.